Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
- 20 September 2007
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 30 (5) , 398-408
- https://doi.org/10.1016/j.ijantimicag.2007.07.011
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Prevalence and Characteristics of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia in a Tertiary Care CenterJournal of Clinical Microbiology, 2007
- The potential clinical impact of low-level antibiotic resistance in Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 2006
- Control and Outcome of a Large Outbreak of Colonization and Infection with Glycopeptide-Intermediate Staphylococcus aureus in an Intensive Care UnitClinical Infectious Diseases, 2006
- MRSA—the tip of the icebergClinical Microbiology & Infection, 2006
- First Report of Vancomycin-Resistant Staphylococci Isolated from Healthy Carriers in BrazilJournal of Clinical Microbiology, 2005
- Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic MethodsAntimicrobial Agents and Chemotherapy, 2003
- A Prospective Multicenter Study of Staphylococcus aureus BacteremiaMedicine, 2003
- Outcome and Attributable Mortality in Critically Ill Patients With Bacteremia Involving Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureusArchives of internal medicine (1960), 2002
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997